- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Kidney Disease Stage 3 and 4 in Japan
Total 887 results
-
Kumamoto UniversityCompletedHemodialysis | Iron Deficiency Anemia | Chronic Renal Failure | Renal AnemiaJapan
-
Akebia TherapeuticsCompletedAnemia | Non-dialysis Dependent Chronic Kidney DiseaseJapan
-
Akebia TherapeuticsCompletedAnemia | Dialysis Dependent Chronic Kidney DiseaseJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedChronic Renal FailureJapan
-
AstraZenecaCompleted
-
KDL Inc.CompletedChronic Kidney Disease | HyperphosphatemiaJapan
-
Astellas Pharma IncFibroGenCompletedHemodialysis Chronic Kidney Disease Patients With AnemiaJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedChronic Renal Failure Patients With Hyperphosphataemia Receiving HemodialysisJapan
-
Yokohama City University Medical CenterCompleted
-
AstraZenecaCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedAnemia; Hemodialysis Dependent Chronic Kidney DiseaseJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedAnemia; Peritoneal Dialysis Dependent Chronic Kidney DiseaseJapan
-
BayerCompletedEnd Stage Renal Disease Requiring HemodialysisBelgium, United States, Latvia, Taiwan, Germany, Japan, Spain, Canada, Bulgaria, Greece, Ukraine, Czechia, Hungary, Korea, Republic of, Russian Federation
-
BayerRecruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseGermany, Japan
-
Astellas Pharma IncFibroGenCompletedESA-naive Hemodialysis Chronic Kidney Disease Patients With AnemiaJapan
-
AbbottAbbott Japan Co.,LtdCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease on HemodialysisJapan
-
Toray Industries, IncAstellas Pharma IncCompletedChronic Renal Failure | Glomerular Disease | NephrosclerosisChina, Hong Kong, Taiwan, Malaysia, Japan, Korea, Republic of, Thailand
-
Astellas Pharma IncFibroGenCompletedChronic Kidney DiseaseJapan
-
Takayuki HamanoThe Japan Kidney Foundation; Molecular Physiological Chemistry Laboratory,... and other collaboratorsCompletedAnemia | Vitamin D Deficiency | Kidney Failure, Chronic | Bone Diseases, MetabolicJapan
-
Novartis PharmaceuticalsCompletedChronic Kidney DiseaseTaiwan, Japan
-
Astellas Pharma IncFibroGenCompletedHemodialysis Patients With Renal AnemiaJapan
-
Kurume UniversityUnknownEffects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic ComplicationsJapan
-
BayerActive, not recruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseJapan, Spain, Netherlands, Denmark, United States
-
Mitsubishi Tanabe Pharma CorporationCompletedAnemia; Hemodialysis Dependent Chronic Kidney DiseaseJapan
-
CANDLE-KIT Trial Study GroupChugai Pharmaceutical; Roche Diagnostics; The Japan Kidney Foundation; Japanese...TerminatedRenal Insufficiency, Chronic | Anemia | Vitamin D Deficiency | Kidney TransplantationJapan
-
AbbottAbbott Japan Co.,LtdCompletedHemodialysis | Secondary HyperparathyroidismJapan
-
Daiichi Sankyo Co., Ltd.CompletedDiabetic Nephropathy | Chronic GlomerulonephritisJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedAnemia; Non-dialysis Dependent Chronic Kidney DiseaseJapan
-
AbbottCompletedHemodialysis | Secondary HyperparathyroidismJapan
-
Kyorin UniversityUnknown
-
Fuji Yakuhin Co., Ltd.Completed
-
Otsuka Pharmaceutical Co., Ltd.CompletedAutosomal Dominant Polycystic Kidney DiseaseJapan
-
Kyorin UniversityOtsuka Pharmaceutical Co., Ltd.CompletedAutosomal Dominant Polycystic Kidney DiseaseJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedAutosomal Dominant Polycystic Kidney DiseaseJapan
-
BayerCompletedHemodialysis | End-stage Renal Disease | Hemodiafiltration | Prevention of Thromboembolic EventsSpain, Greece, Belgium, Russian Federation, Netherlands, Turkey, Japan, Australia, Austria, Bulgaria, Italy, Ukraine, Czechia, Israel, United States, Hungary, Lithuania, Poland, Portugal
-
BayerShireCompleted
-
Kyorin UniversityCompletedDisease Progression | Autosomal Dominant Polycystic Kidney DiseaseJapan
-
AstraZenecaCompletedChronic Kidney DiseaseUnited States, Brazil, Australia, Canada, France, Germany, Italy, Japan, Spain, United Kingdom, China
-
GlaxoSmithKlineTerminated
-
Institute for Clinical Effectiveness, JapanCompletedCoronary Disease | Diabetes Mellitus | Dipeptidyl-Peptidase 4 Inhibitors | LDL Cholesterol | Glycosylated HemoglobinJapan
-
Asahi Kasei Pharma CorporationCompletedPostoperative Stage II/III Colon CancerJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedPolycystic Kidney, Autosomal DominantJapan
-
AstraZenecaActive, not recruiting
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Neoplasms Malignant | Colorectal Cancer Stage IUnited States, Japan, Italy, Spain
-
City of Hope Medical CenterRecruitingGastric Cancer | Gastric Adenocarcinoma | Gastric Cancer Stage IV | Gastric Neoplasm | Gastric Cancer Metastatic to Lung | Gastric Cancer Stage | Gastric Cancer Metastatic to Liver | Gastric Cancer Stage III | Gastric Cancer Stage II | Gastric Lesion | Gastric Cancer in Situ | Gastric Cancer Stage IIIB | Gastric... and other conditionsUnited States, Japan